NEW DELHI: With digital payments constantly growing, financial service providers need to collaborate with fintech developers to build "resilient front-ends" to safeguard consumer interest in view of rising cyber frauds, a top finance ministry official said on Monday. Speaking at a FICCI event on FinTech, K Rajaraman, Additional Secretary in the Finance Ministry, said an area that "needs to be highlighted is cyber security and fraud prevention. Now that there is an explosion in the use of digital platforms. A lot of the activities of fintech have been focused on how to provide resilient front-ends for the financial services providers". Financial service providers must not hesitate to actually collaborate with fintech (financial technology) innovators for beefing up cyber security and fraud prevention, he said. Citing an example of recent cyber attack on New Zealand's stock market, he said, cyber security should get continuous attention from all stakeholders. Last month, New Zealand's … [Read more...] about Fintech companies need to focus on providing resilient front-ends for financial service providers: Government
Pneumococcal polysaccharide vaccine what you need to know
As 38 clinical trials seek tens of thousands of volunteers to receive doses of experimental vaccines, researchers are discussing how to find and recruit participants effectively and ethically. Some people who are especially vulnerable to COVID-19 have not been well represented in studies—or represented at all. Prisoners, for instance, have borne a heavy burden of COVID-19, with more than 125,000 U.S. prisoners infected, and more than 1000 dead. But prisoners have also been excluded from the trials out of concern that they might be coerced into participating or exploited if they do. … [Read more...] about Ethical or exploitative—should prisoners participate in COVID-19 vaccine trials?
Hitting pause on a promising vaccine candidate may be jarring, especially during a deadly pandemic. But it’s not unexpected, and it’s exactly the kind of thing that large-scale clinical trials are for. In clinical trials, researchers carefully monitor patients for any kind of bad reactions to the drug or treatment. If something goes wrong, they can pause, investigate, and then keep going once it’s safe to do so. … [Read more...] about AstraZeneca resumes coronavirus vaccine clinical trials, but only in the UK
Critics have called the timeline unrealistic, noting it’s unlikely that vaccine developers would have sufficient data from the phase 3 trials by that time, let alone the necessary vaccine manufacturing and distribution infrastructure ready. They also pointed out that the pre-election target for a vaccine release appears solely based on politics, not public health. … [Read more...] about COVID vaccine makers vow science—not Trump—will dictate release timing
Transverse myelitis News quickly came to light that the illness might be transverse myelitis, though, which was first reported from an anonymous source of The New York Times. Transverse myelitis is inflammation of the spinal cord that can be triggered by a number of conditions, including inflammatory system disorders (such as multiple sclerosis), vascular disorders, and infections from bacteria, viruses, parasites, or fungi. In rare instances, it can be triggered from a vaccine. AstraZeneca declined to confirm any of those details of the ill participant. In a statement to the Times, the company said that “the event is being investigated by an independent committee and it is too early to conclude the specific diagnosis.” … [Read more...] about “Not uncommon at all”: AstraZeneca pauses COVID-19 vaccine trial